CLINICAL_TRIALS
withdrawal
· 2018-06-07
Clinical Trial Update: Efficacy of Keppra in Acute Alcohol Related Seizure Control--A Pilot Study [Phase 2]
Summary
A Phase 2 pilot study evaluating levetiracetam (Keppra) for acute alcohol-related seizure control was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of South Carolina | Conditions: Seizure, Alcohol Related | Phase 2 | Status: WITHDRAWN